Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

1.

An anesthetic method compatible with (18)F-FDG-PET studies in mice.

Siikanen J, Sjövall J, Forslid A, Brun E, Bjurberg M, Wennerberg J, Ekblad L, Sandell A.

Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):270-7. eCollection 2015.

2.

Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.

Letsolo BT, Faust H, Ekblad L, Wennerberg J, Forslund O.

Head Neck. 2014 Oct 28. doi: 10.1002/hed.23918. [Epub ahead of print]

PMID:
25352201
3.

Anti- or pro-proliferation—conditional options for TGF-α and cetuximab in head and neck squamous cell carcinoma.

Ekblad L, Welinder C, Kjellén E, Brun E, Wennerberg J.

Oral Oncol. 2015 Jan;51(1):46-52. doi: 10.1016/j.oraloncology.2014.08.019. Epub 2014 Sep 26.

PMID:
25261297
4.

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.

Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A.

Clin Cancer Res. 2014 Nov 15;20(22):5733-44. doi: 10.1158/1078-0432.CCR-14-0291. Epub 2014 Sep 11.

PMID:
25212604
5.

Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma.

Lindgren G, Ekblad L, Vallon-Christersson J, Kjellén E, Gebre-Medhin M, Wennerberg J.

BMC Cancer. 2014 Sep 2;14:648. doi: 10.1186/1471-2407-14-648.

6.

High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.

Annertz K, Rosenquist K, Andersson G, Jacobsson H, Hansson BG, Wennerberg J.

Acta Otolaryngol. 2014 Aug;134(8):843-51. doi: 10.3109/00016489.2014.890289. Epub 2014 Jun 16.

PMID:
24930912
7.

Alpha B-crystallin - a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavity.

Annertz K, Enoksson J, Williams R, Jacobsson H, Coman WB, Wennerberg J.

Acta Otolaryngol. 2014 May;134(5):543-50. doi: 10.3109/00016489.2013.872293.

PMID:
24702231
8.

Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3.

Ekblad L, Lindgren G, Persson E, Kjellén E, Wennerberg J.

BMC Cancer. 2013 Jan 25;13:33. doi: 10.1186/1471-2407-13-33.

9.

Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts.

Yamatodani T, Holmqvist B, Kjellén E, Johnsson A, Mineta H, Wennerberg J.

Acta Otolaryngol. 2012 Dec;132(12):1324-33. doi: 10.3109/00016489.2012.699195. Epub 2012 Oct 7.

PMID:
23039202
10.

Increased toxicity of a trinuclear Pt-compound in a human squamous carcinoma cell line by polyamine depletion.

Kjellström J, Oredsson SM, Wennerberg J.

Cancer Cell Int. 2012 May 28;12(1):20. doi: 10.1186/1475-2867-12-20.

11.

Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.

Evans-Axelsson S, Ulmert D, Örbom A, Peterson P, Nilsson O, Wennerberg J, Strand J, Wingårdh K, Olsson T, Hagman Z, Tolmachev V, Bjartell A, Lilja H, Strand SE.

Cancer Biother Radiopharm. 2012 May;27(4):243-51. doi: 10.1089/cbr.2011.1088. Epub 2012 Apr 10.

12.

The increase in incidence of cancer of the tongue in the Nordic countries continues into the twenty-first century.

Annertz K, Anderson H, Palmér K, Wennerberg J.

Acta Otolaryngol. 2012 May;132(5):552-7. doi: 10.3109/00016489.2011.649146. Epub 2012 Feb 19.

PMID:
22339663
13.

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.

Oshima G, Wennerberg J, Yamatodani T, Kjellén E, Mineta H, Johnsson A, Ekblad L.

J Cancer Res Clin Oncol. 2012 Mar;138(3):491-9. doi: 10.1007/s00432-011-1127-5. Epub 2011 Dec 23.

PMID:
22193422
14.

Radiological imaging of the neck for initial decision-making in oral squamous cell carcinomas--a questionnaire survey in the Nordic countries.

Norling R, Grau C, Nielsen MB, Homøe P, Sørensen JA, Lambertsen K, Bundgaard T, Mäkitie A, Grénman R, Larenne J, Koivunen P, Virtaniemi J, Gudjonsson A, Jetlund O, Abendstein H, Rikardsen O, Lybak S, Wennerberg J, Högmo A, Laurell G, Westerborn A, Hammerlid E, Tytor W, Cederblad L, von Buchwald C.

Acta Oncol. 2012 Mar;51(3):355-61. doi: 10.3109/0284186X.2011.640346. Epub 2011 Dec 19.

PMID:
22175252
15.

The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.

Sasaki Y, Kjellén E, Ekblad L, Wahlberg P, Mineta H, Wennerberg J.

Oral Oncol. 2012 Jan;48(1):61-6. doi: 10.1016/j.oraloncology.2011.09.003. Epub 2011 Oct 1.

PMID:
21963040
16.

Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro.

Bjurberg M, Abedinpour P, Brun E, Baldetorp B, Borgström P, Wennerberg J, Kjellén E.

Nucl Med Mol Imaging. 2010 Sep;44(3):165-169. Epub 2010 Jun 9.

17.

No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.

Sasaki Y, Kjellén E, Mineta H, Wennerberg J, Ekblad L.

Acta Oncol. 2009;48(7):1062-9. doi: 10.1080/02841860902913553.

PMID:
19412811
18.

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.

Henriksson E, Kjellén E, Baldetorp B, Bendahl PO, Borg A, Brun E, Mertens F, Ohlsson T, Rennstam K, Wennerberg J, Wahlberg P.

J Exp Clin Cancer Res. 2009 Feb 13;28:17. doi: 10.1186/1756-9966-28-17.

19.

Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, Surralles J, Castella M, van der Wal JE, Wennerberg J, Califano J, Velleuer E, Dietrich R, Ebell W, Bloemena E, Joenje H, Leemans CR, Brakenhoff RH.

J Natl Cancer Inst. 2008 Nov 19;100(22):1649-53. doi: 10.1093/jnci/djn366. Epub 2008 Nov 11.

20.

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.

Yamatodani T, Ekblad L, Kjellén E, Johnsson A, Mineta H, Wennerberg J.

J Cancer Res Clin Oncol. 2009 Mar;135(3):395-402. doi: 10.1007/s00432-008-0475-2. Epub 2008 Sep 24.

PMID:
18813952
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk